A polymer-coated, paclitaxel eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomized non-inferiority trial. Lancet 2018; 392: 1541-1551.

Published: 19th December 2018

Authors: Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y et al.

Conclusion

Two different drug-eluting stents were compared in 465 patients with intermittent claudication due to superficial femoral or proximal popliteal artery disease. At twelve months, patency rates were similar for polymer-coated (86.8 per cent) and polymer-free stents (91 per cent). Adverse event rates and secondary revascularization procedures were similar.

Pubmed Link

Your comments

0 Comments